Efficacy of pirfenidone in patients with advanced IPF
J. Behr (Munich, Germany), W. Wuyts (Leuven, Belgium), H. Haller Jr (Louisville, United States), K. Samara (Basel, Switzerland), K. Kirchgässler (Basel, Switzerland), F. Gilberg (Basel, Switzerland), S. Nathan (Falls Church, United States)
Source: International Congress 2022 – Promising new approaches in idiopathic interstitial pneumonias
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Behr (Munich, Germany), W. Wuyts (Leuven, Belgium), H. Haller Jr (Louisville, United States), K. Samara (Basel, Switzerland), K. Kirchgässler (Basel, Switzerland), F. Gilberg (Basel, Switzerland), S. Nathan (Falls Church, United States). Efficacy of pirfenidone in patients with advanced IPF. 1936
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|